Atlas Trials

Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma.

Clinical trial NCT01993784 · UNKNOWN

Trial details

NCT number
NCT01993784
Sponsor
Peking University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Esophageal Squamous Cell Cancer
Start date
2013-08-01
Primary completion
2014-03-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.